GlobalData on MSN

Revolution’s RAS inhibitor pipeline posts more pancreatic cancer trial wins

The biotech’s G12D-selective RAS blocker has demonstrated its first and second-line combinatory potential in pancreatic ...

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 ...
Oncology Nurse Advisor

GLP-1 RAs Linked to Improved Survival in Patients Receiving ICI Therapy

A real-world analysis investigates the impact of concurrent GLP-1 RA use on long-term survival and the safety profile of patients with solid and hematologic malignancies receiving immune checkpoint ...
Lupus Science & Medicine

Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort

Objective While guidelines advocate renin-angiotensin system inhibitors (RASi) for renoprotection in lupus nephritis (LN), ...

RPSC RAS apply online 2026 last date; registration closes today for 607 posts at rpsc.rajasthan.gov.in

RPSC RAS Recruitment 2026: The Rajasthan Public Service Commission (RPSC) is closing the application portal to apply for the ...

RPSC RAS Syllabus 2026: Check Exam Pattern & Download Prelims Syllabus PDF Here

The RPSC has released the RPSC RAS syllabus for prelims on the official website, rpsc.rajasthan.gov.in. The candidates who ...